Scenario Projections of Respiratory Syncytial Virus Hospitalizations Averted Due to New Immunizations
In this decision analytical model of RSV immunizations, the results suggest a modest reduction in RSV-diagnosed hospitalizations during the 2023 to 2024 season due to limited availability of immunization products, particularly for infants. A higher uptake earlier in the season may lead to substantial reductions in RSV hospitalizations in the 2024 to 2025 season.
Authors
- Helen Y. Chu (ORCID: https://orcid.org/0000-0001-8502-9600)
- Eric J. Chow (ORCID: https://orcid.org/0000-0003-3349-9330)
- Samantha J. Bents (ORCID: https://orcid.org/0009-0003-9298-945X)
- Amanda C. Perofsky (ORCID: https://orcid.org/0000-0001-7341-9193)
- Amanda Adler (ORCID: https://orcid.org/0000-0002-2797-3385)
- Lea M. Starita (ORCID: https://orcid.org/0000-0003-2870-5099)
- Cécile Viboud (ORCID: https://orcid.org/0000-0003-3243-4711)
- Kaiyuan Sun (ORCID: https://orcid.org/0000-0002-1753-9884)
- Lawrence Lee (ORCID: https://orcid.org/0000-0003-3990-2469)
- C. Hansen (ORCID: https://orcid.org/0000-0002-4526-6772)
Institutions
- Roskilde University (DK)
- National Institutes of Health (US)
- Public Health – Seattle & King County (US)
- University of Washington (US)
- Brotman Baty Institute (US)
- Fogarty International Center (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.14622
- Citations
- 4
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- U.S. Department of Health and Human Services
- Council of State and Territorial Epidemiologists
- Seattle Children's Research Institute
- National Institutes of Health
- Centers for Disease Control and Prevention